BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22199228)

  • 21. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.
    Kuzyk MA; Smith D; Yang J; Cross TJ; Jackson AM; Hardie DB; Anderson NL; Borchers CH
    Mol Cell Proteomics; 2009 Aug; 8(8):1860-77. PubMed ID: 19411661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18O-labeled proteome reference as global internal standards for targeted quantification by selected reaction monitoring-mass spectrometry.
    Kim JS; Fillmore TL; Liu T; Robinson E; Hossain M; Champion BL; Moore RJ; Camp DG; Smith RD; Qian WJ
    Mol Cell Proteomics; 2011 Dec; 10(12):M110.007302. PubMed ID: 21988777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
    De Marchi T; Kuhn E; Dekker LJ; Stingl C; Braakman RB; Opdam M; Linn SC; Sweep FC; Span PN; Luider TM; Foekens JA; Martens JW; Carr SA; Umar A
    J Proteome Res; 2016 Apr; 15(4):1230-42. PubMed ID: 26958999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.
    Hoofnagle AN; Becker JO; Oda MN; Cavigiolio G; Mayer P; Vaisar T
    Clin Chem; 2012 Apr; 58(4):777-81. PubMed ID: 22307200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of liquid chromatography-multiple reaction monitoring cubed mass spectrometry assay for protein quantification: application to aquaporin-2 water channel in human urine.
    Jaffuel A; Lemoine J; Aubert C; Simon R; Léonard JF; Gautier JC; Pasquier O; Salvador A
    J Chromatogr A; 2013 Aug; 1301():122-30. PubMed ID: 23816198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of low-abundance serological proteins with peptide affinity-based enrichment and pseudo-multiple reaction monitoring by hybrid quadrupole time-of-flight mass spectrometry.
    Kim KH; Ahn YH; Ji ES; Lee JY; Kim JY; An HJ; Yoo JS
    Anal Chim Acta; 2015 Jul; 882():38-48. PubMed ID: 26043090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuts and Bolts of Protein Quantification by Online Trypsin Digestion Coupled LC-MS/MS Analysis.
    Toth CA; Kuklenyik Z; Barr JR
    Methods Mol Biol; 2019; 1871():295-311. PubMed ID: 30276747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-peptide monoclonal antibodies generated for immuno-multiple reaction monitoring-mass spectrometry assays have a high probability of supporting Western blot and ELISA.
    Schoenherr RM; Saul RG; Whiteaker JR; Yan P; Whiteley GR; Paulovich AG
    Mol Cell Proteomics; 2015 Feb; 14(2):382-98. PubMed ID: 25512614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute quantitation of proteins in human blood by multiplexed multiple reaction monitoring mass spectrometry.
    Percy AJ; Chambers AG; Parker CE; Borchers CH
    Methods Mol Biol; 2013; 1000():167-89. PubMed ID: 23585092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commercially available antibodies can be applied in quantitative multiplexed peptide immunoaffinity enrichment targeted mass spectrometry assays.
    Schoenherr RM; Zhao L; Ivey RG; Voytovich UJ; Kennedy J; Yan P; Lin C; Whiteaker JR; Paulovich AG
    Proteomics; 2016 Aug; 16(15-16):2141-5. PubMed ID: 27094115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.
    Anderson L; Hunter CL
    Mol Cell Proteomics; 2006 Apr; 5(4):573-88. PubMed ID: 16332733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry.
    Burgess MW; Keshishian H; Mani DR; Gillette MA; Carr SA
    Mol Cell Proteomics; 2014 Apr; 13(4):1137-49. PubMed ID: 24522978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).
    Abbatiello SE; Mani DR; Schilling B; Maclean B; Zimmerman LJ; Feng X; Cusack MP; Sedransk N; Hall SC; Addona T; Allen S; Dodder NG; Ghosh M; Held JM; Hedrick V; Inerowicz HD; Jackson A; Keshishian H; Kim JW; Lyssand JS; Riley CP; Rudnick P; Sadowski P; Shaddox K; Smith D; Tomazela D; Wahlander A; Waldemarson S; Whitwell CA; You J; Zhang S; Kinsinger CR; Mesri M; Rodriguez H; Borchers CH; Buck C; Fisher SJ; Gibson BW; Liebler D; Maccoss M; Neubert TA; Paulovich A; Regnier F; Skates SJ; Tempst P; Wang M; Carr SA
    Mol Cell Proteomics; 2013 Sep; 12(9):2623-39. PubMed ID: 23689285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute quantitation of low abundance plasma APL1β peptides at sub-fmol/mL Level by SRM/MRM without immunoaffinity enrichment.
    Sano S; Tagami S; Hashimoto Y; Yoshizawa-Kumagaye K; Tsunemi M; Okochi M; Tomonaga T
    J Proteome Res; 2014 Feb; 13(2):1012-20. PubMed ID: 24354742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Two Peptide Isotopologues as Internal Standards for the Streamlined Quantification of Low-Abundance Proteins by Immuno-MRM and Immuno-MALDI.
    Ibrahim S; Froehlich BC; Aguilar-Mahecha A; Aloyz R; Poetz O; Basik M; Batist G; Zahedi RP; Borchers CH
    Anal Chem; 2020 Sep; 92(18):12407-12414. PubMed ID: 32786432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying protein measurands by peptide measurements: where do errors arise?
    van den Broek I; Romijn FP; Smit NP; van der Laarse A; Drijfhout JW; van der Burgt YE; Cobbaert CM
    J Proteome Res; 2015 Feb; 14(2):928-42. PubMed ID: 25494833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
    Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.
    Keshishian H; Addona T; Burgess M; Mani DR; Shi X; Kuhn E; Sabatine MS; Gerszten RE; Carr SA
    Mol Cell Proteomics; 2009 Oct; 8(10):2339-49. PubMed ID: 19596694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry.
    Razavi M; Frick LE; LaMarr WA; Pope ME; Miller CA; Anderson NL; Pearson TW
    J Proteome Res; 2012 Dec; 11(12):5642-9. PubMed ID: 23126378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute Quantification of Apolipoproteins Following Treatment with Omega-3 Carboxylic Acids and Fenofibrate Using a High Precision Stable Isotope-labeled Recombinant Protein Fragments Based SRM Assay.
    Hober A; Edfors F; Ryaboshapkina M; Malmqvist J; Rosengren L; Percy AJ; Lind L; Forsström B; Uhlén M; Oscarsson J; Miliotis T
    Mol Cell Proteomics; 2019 Dec; 18(12):2433-2446. PubMed ID: 31591263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.